ENTRY       D10083                      Drug
NAME        Tabalumab (USAN);
            Tabalumab (genetical recombination) (JAN)
FORMULA     C6518H10008N1724O2032S38
EXACT_MASS  146160.2177
MOL_WEIGHT  146250.0077
SEQUENCE    (A chain)
            QVQLQQWGAG LLKPSETLSL TCAVYGGSFS GYYWSWIRQP PGKGLEWIGE INHSGSTNYN
            PSLKSRVTIS VDTSKNQFSL KLSSVTAADT AVYYCARGYY DILTGYYYYF DYWGQGTLVT
            VSSASTKGPS VFPLAPCSRS TSESTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL
            QSSGLYSLSS VVTVPSSSLG TKTYTCNVDH KPSNTKVDKR VESKYGPPCP PCPAPEFLGG
            PSVFLFPPKP KDTLMISRTP EVTCVVVDVS QEDPEVQFNW YVDGVEVHNA KTKPREEQFN
            STYRVVSVLT VLHQDWLNGK EYKCKVSNKG LPSSIEKTIS KAKGQPREPQ VYTLPPSQEE
            MTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SRLTVDKSRW
            QEGNVFSCSV MHEALHNHYT QKSLSLSLGK
            (B chain)
            EIVLTQSPAT LSLSPGERAT LSCRASQSVS RYLAWYQQKP GQAPRLLIYD ASNRATGIPA
            RFSGSGSGTD STLTISSLEP EDFAVYYCQQ RSNWPRTFGQ GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSNTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: A22-A95, A137-B214, A150-206, A229-A'229, A232-A'232, A264-A324, A370-A428, A'22-A'95, A'137-B'214, A'150-A'206, A'264-A'324, A'370-A'428, B23-B88, B134-B194, B'23-B'88, B'134-B'194)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody
COMMENT     Autoimmune diseases and B cell malignancies
TARGET      TNFSF13B (BAFF, CD257) [HSA:10673] [KO:K05476]
  PATHWAY   hsa04060(10673)  Cytokine-cytokine receptor interaction
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Tumor necrosis factors
                TNFSF13B (BAFF, CD257)
                 D10083  Tabalumab (USAN)
DBLINKS     PubChem: 135626802
///
